Life Science Outsourcing

Cleanroom Assembly Requirements for Class II and Class III Medical Devices

Class III implantable and life-sustaining devices demand tighter cleanroom classes, more frequent environmental monitoring, and deeper validation than Class II devices. Here is exactly what changes between the two — and the standards that govern each.

Cleanroom Assembly Requirements for Class II and Class III Medical Devices
FDA-Registered
Manufacturing Facility
ISO 13485
Certified Quality System
12 Cleanrooms
Class 5–8
125,000+ Sq Ft
Regulated Manufacturing
3 Facilities
CA | NH | Costa Rica
ISO 17025
Accredited Packaging Lab

Cleanroom assembly of Class II and Class III medical devices must be performed in a classified, environmentally monitored cleanroom — typically ISO 14644-1 Class 7 or Class 8 for Class II devices, and ISO Class 7 or cleaner (often Class 5–6 at the point of assembly) for Class III implantable or life-sustaining devices — under an ISO 13485 / 21 CFR Part 820 quality system, with controlled gowning, particulate and viable (microbial) monitoring, bioburden control, and full lot traceability. The core difference is rigor: Class III devices carry the highest risk, so they require design controls, more frequent monitoring, tighter bioburden limits, and a more extensive validation lifecycle (IQ/OQ/PQ plus process validation) than most Class II devices.

By the LSO Manufacturing & Quality team · Last reviewed June 2026

Class II vs. Class III: Cleanroom Assembly Requirements Compared

Both require a classified cleanroom and an ISO 13485 quality system. What changes between the classes is the degree of rigor.

Comparison of cleanroom assembly requirements for Class II versus Class III medical devices, covering FDA risk class, ISO 14644-1 cleanroom class, environmental and viable monitoring, bioburden control, design controls, documentation, process validation, sterile barrier requirements, and lot traceability.
RequirementClass II devicesClass III devices
FDA risk class & regulatory pathModerate risk; most reach market via 510(k) clearanceHighest risk; most require Premarket Approval (PMA); frequently implantable or life-sustaining
Typical cleanroom class (ISO 14644-1)Commonly ISO 7 or ISO 8 (Class 10,000–100,000)ISO 7 or cleaner; critical assembly zones often ISO 5–6
Environmental monitoringRoutine particle and microbial monitoring under a written EM planMore frequent, higher-density sampling against tighter, trended alert/action limits
Airborne particulate limitsPer the room’s assigned ISO 14644-1 classPer the cleaner assigned class; tightest at the point of assembly
Viable (microbial) monitoringAir, surface, and personnel monitoring per the EM planSame methods, with lower action limits and higher frequency in critical zones
Bioburden control (ISO 11737-1)Bioburden monitored to support the validated sterilization doseTighter bioburden limits and trending; critical to implant sterility assurance
Design controlsRequired for essentially all Class II devicesAlways required; deepest design-file scrutiny
Documentation depth (DMR / DHR / DHF)Full device master record with per-lot device history recordsSame records with deeper detail, more in-process checks, and tighter change control
Process validation (IQ/OQ/PQ)IQ/OQ/PQ for assembly equipment and special processesIQ/OQ/PQ plus broader process validation, more PQ sampling, and clearer revalidation triggers
Sterile barrier (ISO 11607)Validated sterile barrier system where the device is supplied sterileValidated sterile barrier system; integrity is critical for implantables
Lot traceabilityLot-level traceability through the device history recordLot- and often unit/serial-level traceability to support implant tracking

How FDA device class drives cleanroom requirements

The FDA classifies devices by risk: Class I (low), Class II (moderate, usually cleared via 510(k)), and Class III (highest risk, usually requiring Premarket Approval). That risk class drives the regulatory path, the depth of design controls, and how clean and tightly controlled the assembly environment must be. There is no rule that assigns a fixed cleanroom class to a device class — the cleanroom is selected from the device’s contamination-control and sterility-assurance requirements — but in practice the rigor scales with risk. LSO assembles both Class II and Class III devices, including synthetic implantables and cardiac rhythm management devices.

ISO 14644-1 Cleanroom Classes and Typical Device Use

The cleaner the class, the lower the airborne particle limit. Limits below are the published ISO 14644-1:2015 values for particles ≥0.5 µm per cubic meter.

ISO 14644-1 cleanroom classes ISO 5 through ISO 8, their FED-STD-209E equivalents, maximum permitted particles of 0.5 micrometers and larger per cubic meter, and typical medical-device assembly use.
ISO 14644-1 classFED-STD-209E equivalentMax ≥0.5 µm particles / m³Typical medical-device use
ISO 5Class 1003,520Critical aseptic zones; highest-risk implant or drug-device assembly
ISO 6Class 1,00035,200Buffer and support zones around critical aseptic work
ISO 7Class 10,000352,000Common for sterile device assembly and packaging
ISO 8Class 100,0003,520,000General device assembly, kitting, and controlled packaging

Quality system and documentation (21 CFR Part 820 / ISO 13485)

Cleanroom assembly runs inside a medical device quality system. As of February 2, 2026, FDA’s Quality Management System Regulation (QMSR) harmonizes 21 CFR Part 820 with ISO 13485:2016, so a single harmonized quality system can satisfy both — though the QMSR keeps FDA-specific requirements (such as UDI, labeling, MDR reporting, and the §820.35 records provisions) that ISO 13485 alone does not cover. Under QMSR these records are now framed as the Medical Device File (ISO 13485 clause 4.2.3) and the Design and Development File (clause 7.3); the long-standing FDA terms below — DMR, DHR, and DHF — remain common industry shorthand for the same records.

Device Master Record (DMR) — now the Medical Device File

The complete recipe — specifications, drawings, work instructions, process parameters, and acceptance criteria for building the device. Under QMSR this content lives in the Medical Device File (ISO 13485 clause 4.2.3).

Device History Record (DHR)

The per-lot proof of what was actually built — dates, quantities, component lots, in-process and final acceptance records, and labeling. For Class III implants, traceability often extends to the individual unit or serial number.

Design History File (DHF) — now the Design and Development File

The design-controls evidence: design inputs, outputs, verification, validation, and transfer. Under QMSR, design controls are governed by ISO 13485 clause 7.3 (formerly 21 CFR 820.30) and apply to Class III and essentially all Class II devices.

Gowning and environmental monitoring

Gowning escalates with the cleanroom class — from frocks and hairnets in an ISO 8 space to full coveralls, hoods, and double gloves in ISO 5–6 critical zones. Environmental monitoring (EM) tracks both non-viable particulate (to ISO 14644-1, with ongoing monitoring per ISO 14644-2) and viable counts via air, surface, and personnel sampling, trended against alert and action limits. Class III assembly uses tighter limits and more frequent sampling. See LSO’s 12 cleanrooms and cleanroom rental options.

Bioburden control (ISO 11737-1)

Bioburden — the population of viable microorganisms on a device before sterilization — is determined to ISO 11737-1 and is the input that sets and maintains a validated sterilization dose. Cleanroom assembly keeps bioburden low and predictable through environmental control, gowning, and process discipline. Because implant sterility assurance is critical, Class III devices generally carry tighter bioburden limits and trending. LSO runs bioburden and sterility testing alongside sterilization and validation.

Validation lifecycle: IQ/OQ/PQ, process validation, and sterile barrier

Assembly equipment and processes are qualified through Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ). Any process whose output cannot be fully verified by later inspection — sealing, bonding, dispensing — also undergoes process validation. When the device is supplied sterile, the sterile barrier system is validated to ISO 11607-1 and ISO 11607-2, with verified seal strength and seal integrity. Class III devices typically require more PQ sampling, tighter acceptance criteria, and clearer revalidation triggers.

LSO performs Class II and Class III cleanroom assembly across 12 ISO Class 5–8 cleanrooms (125,000+ sq ft, FDA-registered, ISO 13485:2016 certified) → Cleanroom Assembly & Kitting.

FDA-Registered

Manufacturing Facility

ISO 13485

Certified Quality System

12 Cleanrooms

Class 5–8

125,000+ Sq Ft

Regulated Manufacturing

3 Facilities

CA | NH | Costa Rica

ISO 17025

Accredited Packaging Lab

Cleanroom Assembly for Class II/III Devices: FAQ

It requires assembling the device inside a classified, environmentally monitored cleanroom — typically ISO 14644-1 Class 7 or Class 8 for Class II devices, and ISO Class 7 or cleaner for Class III — under an ISO 13485 / 21 CFR Part 820 quality system. That means controlled gowning, routine particulate and viable (microbial) monitoring, bioburden control to ISO 11737-1, validated processes (IQ/OQ/PQ), a validated sterile barrier system to ISO 11607 when the device is sterile, and complete per-lot documentation (device master record, device history record, and design history file). Class III devices add tighter limits, more frequent monitoring, and deeper validation because they carry the highest FDA risk.

No single regulation fixes a cleanroom class to a device class — it is risk- and product-driven and set by your contamination-control and sterility-assurance needs. In practice, Class II device assembly is commonly done in ISO 14644-1 Class 7 or Class 8 cleanrooms, while Class III implantable or life-sustaining devices are assembled in ISO Class 7 or cleaner, often with an ISO Class 5–6 critical zone at the point of assembly.

Both require a classified cleanroom and an ISO 13485 quality system, but Class III (PMA; implantable or life-sustaining) demands more rigor than typical Class II (510(k)) devices: a cleaner cleanroom class, more frequent environmental and viable monitoring, tighter bioburden limits, more extensive process validation and revalidation, and deeper documentation and traceability — often down to the unit or serial level for implant tracking.

Yes for Class III and essentially all Class II devices. Design controls require a design history file (DHF) demonstrating design inputs, outputs, verification, validation, and transfer to manufacturing. Under FDA’s Quality Management System Regulation (QMSR), effective February 2, 2026, 21 CFR Part 820 incorporates ISO 13485:2016, so design controls are governed by ISO 13485 clause 7.3 (formerly 21 CFR 820.30). The assembly process itself is then run to the device master record (DMR) with per-lot device history records (DHR).

Equipment and processes are validated through Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ), plus process validation for any process whose output cannot be fully verified by later inspection. The cleanroom itself is classified and monitored to ISO 14644-1 and -2, and the sterile barrier system is validated to ISO 11607. Class III devices typically require more PQ sampling and tighter acceptance criteria.

Bioburden — the population of viable microorganisms on a device before sterilization — is determined to ISO 11737-1 to set and maintain the validated sterilization dose. Cleanroom assembly controls bioburden through environmental monitoring, gowning, and process control. Class III devices generally carry tighter bioburden limits because sterility assurance is critical for implants.

If the device is supplied sterile, yes. It needs a validated sterile barrier system per ISO 11607-1 and -2, with verified seal strength and seal integrity, that maintains sterility through sterilization, distribution, and aseptic presentation. LSO validates sterile barrier systems in an ISO 17025 accredited packaging lab.

Yes. LSO is an FDA-registered, ISO 13485:2016 certified contract manufacturer with 12 ISO Class 5–8 cleanrooms across 125,000+ sq ft and three facilities (Brea CA, Somersworth NH, and Costa Rica), providing cleanroom assembly, in-house and managed sterilization (EtO, gamma/e-beam, steam) with validation, bioburden and sterility testing, and ISO 11607 sterile barrier packaging — all under one quality system.

Build your Class II or Class III device in an FDA-registered cleanroom

LSO assembles Class II and Class III medical devices in 12 ISO Class 5–8 cleanrooms under one ISO 13485:2016 quality system — with in-house and managed sterilization, validation, and ISO 11607 packaging. Tell us about your device and we’ll map the right cleanroom class and validation plan.

Or call us directly: (714) 672-1090

Cleanroom Assembly Requirements for Class II/III Devices | LSO